} Reuters Shares of CureVac, a German biotech company backed by Bill Gates, went as much as 18% into premarket trading on Thursday after the company said it was in talks with the European Commission to supply doses of its potential coronavirus vaccine. The potential contract with the European Commission …
Read More »This Bill Gates-backed coronavirus vaccine developer has skyrocketed 431% in just 2 days after going public (CVAC)
Reuters CureVac, a German-based biotechnology company, jumped $ 213.3 million and more than a third of its IPO price in its initial public offering on Friday. Shares of the company have continued to grow since its Friday IPO, gaining as much as 52% to $ 85 per share on Monday …
Read More »